Q1 2026 revenue of €197 million for YORVIPATH® and €44 million for SKYTROFA®- More than 1,000 new patient enrollments for YORVIPATH in the U.S.
Ahead of the election, the Southern California News Group compiled a list of questions to pose to the candidates vying to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results